Accelevir serves as a specialized subcontractor for CROs and CDMOs needing fit-for-purpose biomarker assay development and validation.
- Custom Molecular Biomarkers – qPCR/dPCR, targeted sequencing, and allele-specific assays for genetic and epigenetic endpoints.
- Immune Biomarkers – Flow cytometry, ELISpot, ICS, and cytokine multiplex assays for innate and adaptive immune response profiling.
- Rare Sample Optimization – Low-input workflows for scarce preclinical or clinical specimens.